Alex Denner (Mark Neuling/CNBC/NBCU Photo Bank via Getty Images)

Alex Den­ner tar­gets Amarin, de­mand­ing board chair re­sign in call for share­hold­er meet­ing

VC man­ag­ing part­ner and Carl Ic­ahn pro­tégé Alex Den­ner has built him­self a track record as an ac­tivist in­vestor. And he now has an­oth­er biotech …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.